Global Infectious Bursal Disease Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 101

Published Date: 05 Jul 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Infectious Bursal Disease Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Infectious Bursal Disease Vaccine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Infectious Bursal Disease Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Infectious Bursal Disease Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Live
    Inactivated

Market segment by Application can be divided into
    Veterinary Pharmacy
    Online Sale
    Others

The key market players for global Infectious Bursal Disease Vaccine market are listed below:
    Zoetis
    Merck
    Elanco
    Boehringer Ingelheim
    Ceva
    Qingdao Yibang Biological Engineering Co., Ltd.
    Shandong Lvdu Biological Technology Co., Ltd.
    Plyco Bioengineering Co., Ltd.
    Ruipu Biopharmaceutical Co., Ltd.
    Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Infectious Bursal Disease Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Infectious Bursal Disease Vaccine, with price, sales, revenue and global market share of Infectious Bursal Disease Vaccine from 2019 to 2021.
Chapter 3, the Infectious Bursal Disease Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infectious Bursal Disease Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Infectious Bursal Disease Vaccine market forecast, by regions, type and distribution channel, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Infectious Bursal Disease Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Infectious Bursal Disease Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Infectious Bursal Disease Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Live
        1.2.3 Inactivated
    1.3 Market Analysis by Distribution Channel
        1.3.1 Overview: Global Infectious Bursal Disease Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Veterinary Pharmacy
        1.3.3 Online Sale
        1.3.4 Others
    1.4 Global Infectious Bursal Disease Vaccine Market Size & Forecast
        1.4.1 Global Infectious Bursal Disease Vaccine Sales in Value (2016-2026))
        1.4.2 Global Infectious Bursal Disease Vaccine Sales in Volume (2016-2026)
        1.4.3 Global Infectious Bursal Disease Vaccine Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Infectious Bursal Disease Vaccine Production Capacity Analysis
        1.5.1 Global Infectious Bursal Disease Vaccine Total Production Capacity (2016-2026)
        1.5.2 Global Infectious Bursal Disease Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Infectious Bursal Disease Vaccine Market Drivers
        1.6.2 Infectious Bursal Disease Vaccine Market Restraints
        1.6.3 Infectious Bursal Disease Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 Zoetis
        2.1.1 Zoetis Details
        2.1.2 Zoetis Major Business
        2.1.3 Zoetis Infectious Bursal Disease Vaccine Product and Services
        2.1.4 Zoetis Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Infectious Bursal Disease Vaccine Product and Services
        2.2.4 Merck Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Elanco
        2.3.1 Elanco Details
        2.3.2 Elanco Major Business
        2.3.3 Elanco Infectious Bursal Disease Vaccine Product and Services
        2.3.4 Elanco Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Boehringer Ingelheim
        2.4.1 Boehringer Ingelheim Details
        2.4.2 Boehringer Ingelheim Major Business
        2.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product and Services
        2.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Ceva
        2.5.1 Ceva Details
        2.5.2 Ceva Major Business
        2.5.3 Ceva Infectious Bursal Disease Vaccine Product and Services
        2.5.4 Ceva Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Qingdao Yibang Biological Engineering Co., Ltd.
        2.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Details
        2.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Major Business
        2.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Shandong Lvdu Biological Technology Co., Ltd.
        2.7.1 Shandong Lvdu Biological Technology Co., Ltd. Details
        2.7.2 Shandong Lvdu Biological Technology Co., Ltd. Major Business
        2.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.7.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Plyco Bioengineering Co., Ltd.
        2.8.1 Plyco Bioengineering Co., Ltd. Details
        2.8.2 Plyco Bioengineering Co., Ltd. Major Business
        2.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Ruipu Biopharmaceutical Co., Ltd.
        2.9.1 Ruipu Biopharmaceutical Co., Ltd. Details
        2.9.2 Ruipu Biopharmaceutical Co., Ltd. Major Business
        2.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
        2.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Details
        2.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Major Business
        2.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Infectious Bursal Disease Vaccine Sales by Manufacturer
    3.1 Global Infectious Bursal Disease Vaccine Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Infectious Bursal Disease Vaccine Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Infectious Bursal Disease Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Infectious Bursal Disease Vaccine Manufacturer Market Share
        3.4.2 Top 6 Infectious Bursal Disease Vaccine Manufacturer Market Share
    3.5 Global Infectious Bursal Disease Vaccine Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Infectious Bursal Disease Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Infectious Bursal Disease Vaccine Market Size by Region
        4.1.1 Global Infectious Bursal Disease Vaccine Sales in Volume by Region (2016-2026)
        4.1.2 Global Infectious Bursal Disease Vaccine Revenue by Region (2016-2026)
    4.2 North America Infectious Bursal Disease Vaccine Revenue (2016-2026)
    4.3 Europe Infectious Bursal Disease Vaccine Revenue (2016-2026)
    4.4 Asia-Pacific Infectious Bursal Disease Vaccine Revenue (2016-2026)
    4.5 South America Infectious Bursal Disease Vaccine Revenue (2016-2026)
    4.6 Middle East and Africa Infectious Bursal Disease Vaccine Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Infectious Bursal Disease Vaccine Sales in Volume by Type (2016-2026)
    5.2 Global Infectious Bursal Disease Vaccine Revenue by Type (2016-2026)
    5.3 Global Infectious Bursal Disease Vaccine Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Infectious Bursal Disease Vaccine Sales in Volume by Application (2016-2026)
    6.2 Global Infectious Bursal Disease Vaccine Revenue by Application (2016-2026)
    6.3 Global Infectious Bursal Disease Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Infectious Bursal Disease Vaccine Sales by Type (2016-2026)
    7.2 North America Infectious Bursal Disease Vaccine Sales by Application (2016-2026)
    7.3 North America Infectious Bursal Disease Vaccine Market Size by Country
        7.3.1 North America Infectious Bursal Disease Vaccine Sales in Volume by Country (2016-2026)
        7.3.2 North America Infectious Bursal Disease Vaccine Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Infectious Bursal Disease Vaccine Sales by Type (2016-2026)
    8.2 Europe Infectious Bursal Disease Vaccine Sales by Application (2016-2026)
    8.3 Europe Infectious Bursal Disease Vaccine Market Size by Country
        8.3.1 Europe Infectious Bursal Disease Vaccine Sales in Volume by Country (2016-2026)
        8.3.2 Europe Infectious Bursal Disease Vaccine Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Infectious Bursal Disease Vaccine Sales by Type (2016-2026)
    9.2 Asia-Pacific Infectious Bursal Disease Vaccine Sales by Application (2016-2026)
    9.3 Asia-Pacific Infectious Bursal Disease Vaccine Market Size by Region
        9.3.1 Asia-Pacific Infectious Bursal Disease Vaccine Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Infectious Bursal Disease Vaccine Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Infectious Bursal Disease Vaccine Sales by Type (2016-2026)
    10.2 South America Infectious Bursal Disease Vaccine Sales by Application (2016-2026)
    10.3 South America Infectious Bursal Disease Vaccine Market Size by Country
        10.3.1 South America Infectious Bursal Disease Vaccine Sales in Volume by Country (2016-2026)
        10.3.2 South America Infectious Bursal Disease Vaccine Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type (2016-2026)
    11.2 Middle East & Africa Infectious Bursal Disease Vaccine Sales by Application (2016-2026)
    11.3 Middle East & Africa Infectious Bursal Disease Vaccine Market Size by Country
        11.3.1 Middle East & Africa Infectious Bursal Disease Vaccine Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Infectious Bursal Disease Vaccine Typical Distributors
    12.3 Infectious Bursal Disease Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Infectious Bursal Disease Vaccine Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Infectious Bursal Disease Vaccine Revenue by Application, (USD Million), 2021-2026
    Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
    Table 4. Zoetis Major Business
    Table 5. Zoetis Infectious Bursal Disease Vaccine Product and Services
    Table 6. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Merck Basic Information, Manufacturing Base and Competitors
    Table 8. Merck Major Business
    Table 9. Merck Infectious Bursal Disease Vaccine Product and Services
    Table 10. Merck Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Elanco Basic Information, Manufacturing Base and Competitors
    Table 12. Elanco Major Business
    Table 13. Elanco Infectious Bursal Disease Vaccine Product and Services
    Table 14. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 16. Boehringer Ingelheim Major Business
    Table 17. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product and Services
    Table 18. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Ceva Basic Information, Manufacturing Base and Competitors
    Table 20. Ceva Major Business
    Table 21. Ceva Infectious Bursal Disease Vaccine Product and Services
    Table 22. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Qingdao Yibang Biological Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 24. Qingdao Yibang Biological Engineering Co., Ltd. Major Business
    Table 25. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 26. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Shandong Lvdu Biological Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 28. Shandong Lvdu Biological Technology Co., Ltd. Major Business
    Table 29. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 30. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Plyco Bioengineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 32. Plyco Bioengineering Co., Ltd. Major Business
    Table 33. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 34. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 36. Ruipu Biopharmaceutical Co., Ltd. Major Business
    Table 37. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 38. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 40. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Major Business
    Table 41. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 42. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Global Infectious Bursal Disease Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
    Table 44. Global Infectious Bursal Disease Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 45. Market Position of Manufacturers in Infectious Bursal Disease Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 46. Global Infectious Bursal Disease Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
    Table 47. Head Office and Infectious Bursal Disease Vaccine Production Site of Key Manufacturer
    Table 48. Infectious Bursal Disease Vaccine New Entrant and Capacity Expansion Plans
    Table 49. Infectious Bursal Disease Vaccine Mergers & Acquisitions in the Past Five Years
    Table 50. Global Infectious Bursal Disease Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 51. Global Infectious Bursal Disease Vaccine Sales by Region (2021-2026) & (K Units)
    Table 52. Global Infectious Bursal Disease Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 53. Global Infectious Bursal Disease Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 54. Global Infectious Bursal Disease Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 55. Global Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units)
    Table 56. Global Infectious Bursal Disease Vaccine Revenue by Type (2016-2021e) & (USD Million)
    Table 57. Global Infectious Bursal Disease Vaccine Revenue by Type (2021-2026) & (USD Million)
    Table 58. Global Infectious Bursal Disease Vaccine Price by Type (2016-2021e) & (US$/Unit)
    Table 59. Global Infectious Bursal Disease Vaccine Price by Type (2021-2026) & (US$/Unit)
    Table 60. Global Infectious Bursal Disease Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 61. Global Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units)
    Table 62. Global Infectious Bursal Disease Vaccine Revenue by Application (2016-2021e) & (USD Million)
    Table 63. Global Infectious Bursal Disease Vaccine Revenue by Application (2021-2026) & (USD Million)
    Table 64. Global Infectious Bursal Disease Vaccine Price by Application (2016-2021e) & (US$/Unit)
    Table 65. Global Infectious Bursal Disease Vaccine Price by Application (2021-2026) & (US$/Unit)
    Table 66. North America Infectious Bursal Disease Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 67. North America Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units)
    Table 68. North America Infectious Bursal Disease Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 69. North America Infectious Bursal Disease Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 70. North America Infectious Bursal Disease Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 71. North America Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units)
    Table 72. North America Infectious Bursal Disease Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 73. North America Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units)
    Table 74. Europe Infectious Bursal Disease Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 75. Europe Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units)
    Table 76. Europe Infectious Bursal Disease Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 77. Europe Infectious Bursal Disease Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 78. Europe Infectious Bursal Disease Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 79. Europe Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units)
    Table 80. Europe Infectious Bursal Disease Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 81. Europe Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units)
    Table 82. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 83. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Region (2021-2026) & (K Units)
    Table 84. Asia-Pacific Infectious Bursal Disease Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 85. Asia-Pacific Infectious Bursal Disease Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 86. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 87. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units)
    Table 88. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 89. Asia-Pacific Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units)
    Table 90. South America Infectious Bursal Disease Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 91. South America Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units)
    Table 92. South America Infectious Bursal Disease Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 93. South America Infectious Bursal Disease Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 94. South America Infectious Bursal Disease Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 95. South America Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units)
    Table 96. South America Infectious Bursal Disease Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 97. South America Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units)
    Table 98. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 99. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2021-2026) & (K Units)
    Table 100. Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 101. Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 102. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 103. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Type (2021-2026) & (K Units)
    Table 104. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 105. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Application (2021-2026) & (K Units)
    Table 106. Direct Channel Pros & Cons
    Table 107. Indirect Channel Pros & Cons
    Table 108. Infectious Bursal Disease Vaccine Typical Distributors
    Table 109. Infectious Bursal Disease Vaccine Typical Customers
List of Figures
    Figure 1. Infectious Bursal Disease Vaccine Picture
    Figure 2. Global Infectious Bursal Disease Vaccine Sales Market Share by Type in 2020
    Figure 3. Live
    Figure 4. Inactivated
    Figure 5. Global Infectious Bursal Disease Vaccine Sales Market Share by Application in 2020
    Figure 6. Veterinary Pharmacy
    Figure 7. Online Sale
    Figure 8. Others
    Figure 9. Global Infectious Bursal Disease Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 10. Global Infectious Bursal Disease Vaccine Market Size and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Infectious Bursal Disease Vaccine Sales (2016-2026) & (K Units)
    Figure 12. Global Infectious Bursal Disease Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 13. Global Infectious Bursal Disease Vaccine Production Capacity (2016-2026) & (K Units)
    Figure 14. Global Infectious Bursal Disease Vaccine Production Capacity by Geographic Region: 2020 VS 2021
    Figure 15. Infectious Bursal Disease Vaccine Market Drivers
    Figure 16. Infectious Bursal Disease Vaccine Market Restraints
    Figure 17. Infectious Bursal Disease Vaccine Market Trends
    Figure 18. Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturer in 2020
    Figure 19. Global Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturer in 2020
    Figure 20. Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 21. Top 3 Infectious Bursal Disease Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 22. Top 6 Infectious Bursal Disease Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 23. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2016-2026)
    Figure 24. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2016-2026)
    Figure 25. North America Infectious Bursal Disease Vaccine Revenue (2016-2026) & (USD Million)
    Figure 26. Europe Infectious Bursal Disease Vaccine Revenue (2016-2026) & (USD Million)
    Figure 27. Asia-Pacific Infectious Bursal Disease Vaccine Revenue (2016-2026) & (USD Million)
    Figure 28. South America Infectious Bursal Disease Vaccine Revenue (2016-2026) & (USD Million)
    Figure 29. Middle East & Africa Infectious Bursal Disease Vaccine Revenue (2016-2026) & (USD Million)
    Figure 30. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2026)
    Figure 31. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2016-2026)
    Figure 32. Global Infectious Bursal Disease Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 33. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2016-2026)
    Figure 34. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2016-2026)
    Figure 35. Global Infectious Bursal Disease Vaccine Price by Application (2016-2026) & (US$/Unit)
    Figure 36. North America Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2026)
    Figure 37. North America Infectious Bursal Disease Vaccine Sales Market Share by Application (2016-2026)
    Figure 38. North America Infectious Bursal Disease Vaccine Sales Market Share by Country (2016-2026)
    Figure 39. North America Infectious Bursal Disease Vaccine Revenue Market Share by Country (2016-2026)
    Figure 40. United States Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Canada Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Mexico Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Europe Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2026)
    Figure 44. Europe Infectious Bursal Disease Vaccine Sales Market Share by Application (2016-2026)
    Figure 45. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country (2016-2026)
    Figure 46. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country (2016-2026)
    Figure 47. Germany Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. France Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. United Kingdom Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Russia Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Italy Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share by Region (2016-2026)
    Figure 53. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share by Application (2016-2026)
    Figure 54. Asia-Pacific Infectious Bursal Disease Vaccine Sales Market Share by Region (2016-2026)
    Figure 55. Asia-Pacific Infectious Bursal Disease Vaccine Revenue Market Share by Region (2016-2026)
    Figure 56. China Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Japan Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Korea Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. India Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Southeast Asia Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Australia Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. South America Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2026)
    Figure 63. South America Infectious Bursal Disease Vaccine Sales Market Share by Application (2016-2026)
    Figure 64. South America Infectious Bursal Disease Vaccine Sales Market Share by Country (2016-2026)
    Figure 65. South America Infectious Bursal Disease Vaccine Revenue Market Share by Country (2016-2026)
    Figure 66. Brazil Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Argentina Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Type (2016-2026)
    Figure 69. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Application (2016-2026)
    Figure 70. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country (2016-2026)
    Figure 71. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country (2016-2026)
    Figure 72. Turkey Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Egypt Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Saudi Arabia Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. South Africa Infectious Bursal Disease Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Sales Channel: Direct Channel vs Indirect Channel
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Related Reports

Global Infectious Bursal Disease Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Infectious Bursal Disease Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 17 Jan 2022

date Pharma & Healthcare

The Infectious Bursal Disease Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Infectious Bursal Disease Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Infectious Bursal Disease Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.

Global Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2023-2029

Global Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

The global Infectious Bursal Disease Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Infectious Bursal Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Infectious Bursal Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Infectious Bursal Disease Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2024-2030

Global Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2024-2030

date 03 Mar 2024

date Pharma & Healthcare

The global Infectious Bursal Disease Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

newcastle disease infectious bronchitis infectious bursal disease vaccine

Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine

infectious bursal disease vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>